Monoethylglycinexylidide Formation Kinetics: A Novel Approach to Assessment of Liver Function
Authors:
- E. RaudeERE. Raude
- M. BurdelskiMBM. Burdelski
- M. SchulzMSM. Schulz
- F W. SchmidtFSF W. Schmidt
- B. RingeBRB. Ringe
- P. LameschPLP. Lamesch
- R. PichlmayrRPR. Pichlmayr
- H. RaithHRH. Raith
- M. ScheruhnMSM. Scheruhn
- M. WrengerMWM. Wrenger
- Ch. WittekindCWCh. Wittekind
- 1 January 1987
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 25 (12) , 845-854
Abstract
A novel quantitative liver function test is described which is based on monoethylglycinexylidide (MEGX) formation after lidocaine bolus injection. Following the administration of small single doses of lidocaine hydrochloride (1 mg/kg), monoethylglycinexylidide serum concentration-time curves were determined by a novel highly sensitive fluorescence polarisation immunoassay (FPIA) in healthy volunteers, liver donors and patients with liver cirrhosis. The FPIA allowed rapid and reliable monoethylglycinexylidide determinations in serum and urine (between-days coefficient of variation: less than 10.3%, recovery: 80-113%). Monoethylglycinexylidide concentrations measured by FPIA in 32 serum samples from patients correlated well those determined by HPLC. The monoethylglycinexylidide concentration in serum determined 15 min after a lidocaine bolus injection proved to be a highly sensitive and specific indicator of hepatic dysfunction. Average monoethylglycinexylidide concentrations in serum obtained 15 min after lidocaine injection were substantially lower in patients with liver cirrhosis than in healthy volunteers. The average monoethylglycinexylidide concentrations in serum were also substantially lower in liver donors with ballooning or fatty changes of hepatocytes than in donors without relevant alterations of liver histology. By means of monoethylglycinexylidide formation in the liver donors, primary function of the transplanted liver was correctly predicted in 32/37 cases and initial non-function in 4/6 cases.Keywords
This publication has 8 references indexed in Scilit:
- The pharmacokinetics and pharmacodynamics of lignocaine and MEGX in healthy subjectsJournal of Pharmacokinetics and Biopharmaceutics, 1987
- An enzyme-distributed system for lidocaine metabolism in the perfused rat liver preparationJournal of Pharmacokinetics and Biopharmaceutics, 1986
- Hepatic Disease and Drug PharmacokineticsClinical Pharmacokinetics, 1980
- High-performance liquid chromatographic method for the simultaneous determination of lidocaine and its N-dealkylated metabolites in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1979
- Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.BMJ, 1977
- Wilms's Tumor in Three Children of a Woman with Congenital HemihypertrophyNew England Journal of Medicine, 1974
- THE TISSUE DISTRIBUTION, METABOLISM AND EXCRETION OF LIDOCAINE IN RATS, GUINEA PIGS, DOGS AND MANThe Journal of Pharmacology and Experimental Therapeutics, 1972
- Zum Problem der NachweisgrenzeAnalytical and Bioanalytical Chemistry, 1965